
POSITION STATEMENTS
For General Public

POSITION STATEMENTS
For General Public
THE REPORTED ASSOCIATION BETWEEN USE OF ZOLEDRONIC ACID (ACLASTA) AND RENAL IMPAIRMENT
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
Osteonecrosis of bone: Our team of experts weighs in
Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]
Osteonecrosis of the Jaw
A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]
THE REPORTED ASSOCIATION BETWEEN USE OF ZOLEDRONIC ACID (ACLASTA) AND RENAL IMPAIRMENT
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
Osteonecrosis of bone: Our team of experts weighs in
Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]
Osteonecrosis of the Jaw
A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]